Position in CRNX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,152,533
-$1,378,744 QoQ
Shares Held
191,142
-18.6% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 266 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. CRNX ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in CRNX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,152,533 | 191,142 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $8,531,277 | 234,892 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,866,750 | 190,478 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,477,774 | 203,548 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,823,382 | 202,482 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $5,859,236 | 174,694 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $11,708,974 | 229,004 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $10,737,234 | 210,122 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $9,181,860 | 204,998 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $11,009,618 | 235,198 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,277,237 | 176,426 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,146,529 | 139,426 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,061,378 | 58,900 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $443,256 | 27,600 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||